Integrin-mediated activation of latent transforming growth factor β

Cancer and Metastasis Reviews

Volumn 24, Issue 3, 2005, Pages 395-402

  Sheppard, Dean ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

v integrins; Pulmonary fibrosis; Transforming growth factor activation

Indexed keywords

INTEGRIN; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA;

ACTIN POLYMERIZATION; ALLELE; CANCER INVASION; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CYTOPLASM; EPITHELIUM CELL; FIBROSIS; GENE EXPRESSION; LIGATION; LUNG EMPHYSEMA; LUNG INJURY; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; ANTIGENS, NEOPLASM; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CYTOPLASM; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRINS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 27644538315     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-005-5131-6     Document Type: Review

References (45)

1. Hynes RO: Integrins: A family of cell surface receptors. Cell 48: 549-554, 1987
2. Ruoslahti E, MD Pierschbacher: New perspectives in cell adhesion: RGD and integrins. Science 238: 491-497, 1987
3. Clark EA, Brugge JS: Integrins and signal transduction pathways: The road taken. Science 268: 233-239, 1995
4. Constantin G, Majeed M, Giagulli C, Piccio L, Kim JY, Butcher EC, Laudanna C: Chemokines trigger immediate beta2 integrin affinity and mobility changes: Differential regulation and roles in lymphocyte arrest under flow. Immunity 13: 759-769, 2000
5. Barnard, JA, RM Lyons, and HL Moses: The cell biology of transforming growth factor beta. Biochim Biophys Acta 1032: 79-87, 1990
6. Munger JS, Harpel JG, Gleizes P, Mazzieri R, Nunes I, Rifkin DB: Latent transforming growth factor-beta: Structural features and mechanisms of activation. Kidney International 51: 1376-1382, 1997
7. Taipale J, Miyazono K, Heldin CH, Keski-Oja J: Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol 124: 171-181, 1994
8. Nunes I, Gleizes PE, Metz CN, Rifkin DB: Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 136: 1151-1163, 1997
9. Schultz-Cherry S, Murphy-Ullrich JE: Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 122: 923-932, 1993
10. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N: Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93: 1159-1170, 1998
11. Munger JS, Huang XZ, Kawakatsu H, Griffiths MJD, Dalton SL, Wu JF, Pittet JF, Kaminisk N, Garat C, Matthay MA, Rifkin DB, Sheppard D: The integrin αvβ6 binds and activates latent TGFβ1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328, 1999
12. Busk M, Pytela R, Sheppard D: Characterization of the integrin αvβ6 as a fibronectin-binding protein. J Biol Chem 267: 5790-5796, 1992
13. Breuss JM, Gillett N, Lu L, Sheppard D, Pytela R: Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues. J Histochem Cytochem 41: 1521-1527, 1993
14. Breuss JM, Gallo J, DeLisser HM, Klimanskaya IV, Folkesson HG, Pittet JF, Nishimura SL, Aldape K, Landers DV, Carpenter W, Gillett N, Sheppard D, Matthay M, Albelda SM, Kramer RH, Pytela R: Expression of the β6 integrin in development, neoplasia, and tissue repair suggests a role in epithelial remodeling. J. Cell Sci. 108: 2241-2251, 1995
15. Huang XZ, Wu JF, Cass D, Erle DJ, Corry D, Young SG, Farese RVJ, Sheppard D: Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin. J Cell Biol 133: 921-928, 1996
16. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699, 1992
17. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360: 361-364, 1992
18. Giri S, Hyde DM, Hollinger MA: Effect of antibody to transforming growth factor-beta on bleomycin induced accumulation of lung collagen in mice. Thorax 48: 959-966, 1993
19. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB: An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 216: 276-284, 1994
20. Annes JP, Rifkin DB, Munger JS: The integrin alphaV-beta6 binds and activates latent TGFbeta3. FEBS Lett 511:65-68, 2002
21. Annes JP, Chen JS, Munger JS, Rifkin DB: Integrin αvβ6- mediated activation of latent TGF-β requires the latent TGF-β binding protein-1. J Cell Biol 165: 723-731, 2004
22. Ludbrook SB, Barry ST, Delves CJ, Horgan CM: The integrin alphavbeta3 is a receptor for the latency-associated pep tides of transforming growth factors beta1 and beta3. Biochem J 369: 311-318, 2003
23. Lu M, Munger JS, Steadele M, Busald C, Tellier M, Schnapp LM: Integrin alpha8beta1 mediates adhesion to LAP-TGFbetal. J Cell Sci 115: 4641-4648, 2002
24. Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H, Sheppard D, Broaddus VC, Nishimura SL: The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol 157: 493-507, 2002
25. Munger JS, Harpel JG, Giancotti FG, Rifkin DB: Interactions between growth factors and integrins: Latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1. Mol Biol Cell 9: 2627-2638, 1998
26. Zhu J, Motejlek K, Wang D, Zang K, Schmidt A, Reichardt LF: beta8 integrins are required for vascular morphogenesis in mouse embryos. Development 129: 2891-2903, 2002
27. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MW, Doetschman T: Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet 11: 409-414, 1995
28. Bader BL, Rayburn H, Crowley D, Hynes RO: Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell 95: 507-519, 1998
29. Ma LJ, Yang H, Gaspert A, Carlesso G, Barty MM, Davidson JM, Sheppard D, Fogo AB: Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice. Am J Pathol 163: 1261-1273, 2003
30. Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, Morris D, Huang X, Sheppard D, Heller RA: Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci USA 97: 1778-1783, 2000
31. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, Glick A, Sheppard D: Loss of integrin alphavbeta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature 422: 169-173, 2003
32. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD: Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277: 2002-2004, 1997
33. Huang XZ, Wu JF, Zhu W, Pytela R, Sheppard D: Expression of the Human Integrin beta6 Subunit in Alveolar Type II Cells and Bronchiolar Epithelial Cells Reverses Lung Inflammation in beta6 Knockout Mice. Am J Respir Cell Mol Biol 19: 636-642, 1998
34. Pittet JF, Griffiths MJ, Geiser T, Kaminski N, Dalton SL, Huang X, Brown LA, Gotwals PJ, Koteliansky VE, Matthay MA, Sheppard D: TGF-beta is a critical mediator of acute lung injury. J Clin Invest 107: 1537-1544, 2001
35. Derynck R, Akhurst RJ, Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129, 2001
36. Akhurst RJ, R Derynck: TGF-beta signaling in cancer-a double-edged sword. Trends Cell Biol 11: S44-S51, 2001
37. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A, Akhurst RJ: TGFbetal inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86: 531-542, 1996
38. Oft M, Heider KH, Beug H: TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8: 1243-1252, 1998
39. Portella G, Cumming SA, Liddell J, Cui W, Ireland H, Akhurst RJ, Balmain A: Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: Implications for tumor invasion. Cell Growth Differ 9: 393-404, 1998
40. Agrez M, Chen A, Cone R, Pytela R, Sheppard D: The alpha v beta 6 integrin promotes proliferation of colon carcinoma cells through a unique region of the beta 6 cytoplasmic domain. J Cell Biol 127: 547-56, 1994
41. Xue H, Atakilit A, Zhu W, Li X, Ramos DM, Pytela R: Role of the alpha(v)beta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro. Biochem Biophys Res Commun 288: 610-618, 2001
42. Dixit RB, Chen A, Chen J, Sheppard D: Identification of a sequence within the integrin beta6 subunit cytoplasmic domain that is required to support the specific effect of alphavbeta6 on proliferation in three-dimensional culture. J. Biol. Chem. 271: 25976-25980, 1996
43. Morgan MR, Thomas GJ, Russell A, Hart IR, Marshall JF: The integrin cytoplasmic-tail motif EKQKVDL-STDC is sufficient to promote MMP-2 or MMP-9-mediated tumour cell invasion. J Biol Chem 2004
44. Thomas GJ, Lewis MP, Whawell SA, Russell A, Sheppard D, Hart IR, Speight PM, Marshall JF: Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol 117: 67-73, 2001
45. Niu J, Gu X, Turton J, Meldrum C, Howard EW, Agrez M: Integrin-mediated signalling of gelatinase B secretion in colon cancer cells. Biochem Biophys Res Commun 249: 287-291, 1998.